sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
abiraterone mylan
mylan ireland limited - acetato de abiraterona - neoplasias prostáticas - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
rasagilina generis 1 mg comprimido
generis farmacêutica, s.a. - rasagilina - comprimido - 1 mg - rasagilina, tartarato 1.44 mg - rasagiline - genérico - duração do tratamento: longa duração
rasagilina generis 1 mg comprimido
generis farmacêutica, s.a. - rasagilina - comprimido - 1 mg - rasagilina, tartarato 1.44 mg - rasagiline - genérico - duração do tratamento: longa duração
imatinib fresenius kabi 100 mg comprimido revestido por película
fresenius kabi deutschland gmbh - imatinib - comprimido revestido por película - 100 mg - imatinib, mesilato 119.5 mg - imatinib - genérico - duração do tratamento: longa duração
atazanavir generis 300 mg cápsula
generis farmacêutica, s.a. - atazanavir - cápsula - 300 mg - atazanavir, sulfato 342 mg - atazanavir - genérico - duração do tratamento: longa duração
imatinib fresenius kabi 100 mg comprimido revestido por película
fresenius kabi deutschland gmbh - imatinib - comprimido revestido por película - 100 mg - imatinib, mesilato 119.5 mg - imatinib - genérico - duração do tratamento: longa duração
imatinib fresenius kabi 400 mg comprimido revestido por película
fresenius kabi deutschland gmbh - imatinib - comprimido revestido por película - 400 mg - imatinib, mesilato 478 mg - imatinib - genérico - duração do tratamento: longa duração
imatinib fresenius kabi 400 mg comprimido revestido por película
fresenius kabi deutschland gmbh - imatinib - comprimido revestido por película - 400 mg - imatinib, mesilato 478 mg - imatinib - genérico - duração do tratamento: longa duração
atazanavir generis 200 mg cápsula
generis farmacêutica, s.a. - atazanavir - cápsula - 200 mg - atazanavir, sulfato 228 mg - atazanavir - genérico - duração do tratamento: longa duração